A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids
Status:
Completed
Trial end date:
2001-07-01
Target enrollment:
Participant gender:
Summary
This study was designed to determine the safety and effectiveness of 3 asoprisnil doses
compared to placebo, taken for 12 weeks by women with uterine fibroids.